ACADIA Pharmaceuticals Inc. (ACAD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ACADIA Pharmaceuticals Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 11.57x | 13.43x | -83.69x | -11.92x | -22.31x | -29.87x |
| P/B Ratio | 3.69x | 4.15x | 11.88x | 6.43x | 6.93x | 13.41x |
| P/S Ratio | 4.22x | 3.17x | 7.06x | 4.98x | 7.74x | 19.04x |
| Profitability | ||||||
| Gross Margin | 91.7% | 91.5% | 93.7% | 98.0% | 96.0% | 95.3% |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% |
| EBITDA Margin | 13.0% | 10.5% | -9.3% | -42.8% | -34.5% | -64.2% |
| Liquidity | ||||||
| Current Ratio | 3.83x | 2.38x | 2.42x | 4.04x | 6.43x | 6.77x |
| Quick Ratio | 3.71x | 2.32x | 2.28x | 3.99x | 6.35x | 6.68x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.07x | 0.13x | 0.15x | 0.12x | 0.08x |
YoY = year-over-year change. Source: FMP..